1) Hachulla AL,
Launay D,
Gaxotte V,
De Groote P,
Lamblin N,
Devos P,
Hatron PY,
Beregi JP,
Hachulla E.
Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients.
Ann Rheum Dis 2009;68:1878–1884.
doi:10.1136/ard.2008.095836.
2) Sano M,
Satoh H,
Suwa K,
Nobuhara M,
Saitoh T,
Saotome M,
Urushida T,
Katoh H,
Shimoyama K,
Suzuki D,
Ogawa N,
Takehara Y,
Sakahara H,
Hayashi H.
Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.
Heart Vessels (2015) 30:779–788.
DOI 10.1007/s00380-014-0539-y.
3) Steen VD,
Medsger TA Jr.
Improvement in skin thickening in systemic sclerosis associated with improved survival.
Arthritis Rheum 2001 Dec;44(12):2828-35.
4) Amjadi S,
Maranian P,
Furst DE,
Clements PJ,
Wong WK,
Postlethwaite AE,
Khanna PP,
Khanna D.
Course of the Modified Rodnan Skin Thickness Score in Systemic Sclerosis Clinical Trials.
Arthritis & Rheumatism Vol.
60,
No.
8,
August 2009,
pp 2490–2498.
DOI 10.1002/art.24681.
5) Tzelepis GE,
Kelekis NL,
Plastiras SC,
Mitseas P,
Economopoulos N,
Kampolis C,
Gialafos EJ,
Moyssakis I,
Moutsopoulos HM.
Pattern and Distribution of Myocardial Fibrosis in Systemic Sclerosis.
Arthritis&Rheumatism Vol.
56,
No.
11,
November 2007,
pp 3827–3836.
DOI 10.1002/art.22971.
6) Meune C,
Vignaux O,
Kahan A,
Allanore Y.
Heart involvement in systemic sclerosis: Evolving concept and diagnostic methodologies.
Archives of Cardiovascular Disease (2010) 103,
46—52.
7) Allanore Y,
Meune C,
Vonk M C,
Airo P,
Hachulla E,
EUSTAR co-authors.
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.
Ann Rheum Dis 2010;69:218–221.
doi:10.1136/ard.2008.103382.